Resistance to chemotherapy and molecularly targeted therapies: Rationale for combination therapy in malignant melanoma

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint Dive into the research topics of 'Resistance to chemotherapy and molecularly targeted therapies: Rationale for combination therapy in malignant melanoma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences